Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2013, Article ID 594704, 3 pages
http://dx.doi.org/10.1155/2013/594704
Case Report

Whole-Body 18FDG-PET in an Arthritis Paraneoplastic Syndrome Revealed an Underlying Hematological Neoplasm

1Service de Médecine Nucléaire, AP-HM, Faculté de Médecine de Marseille, Hôpital La Timone, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005 Marseille, France
2Service de Rhumatologie, AP-HM, Faculté de Médecine de Marseille, Hôpital Sainte Marguerite, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005 Marseille, France
3Service de Rhumatologie 1, Hôpital de Sainte Marguerite, 270 Bd de Sainte Marguerite, 13009 Marseille, France

Received 16 March 2013; Revised 27 April 2013; Accepted 19 May 2013

Academic Editor: Larry W. Moreland

Copyright © 2013 Serge Cammilleri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. G. Fam, “Paraneoplastic rheumatic syndromes,” Bailliere's Best Practice and Research in Clinical Rheumatology, vol. 14, no. 3, pp. 515–533, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Hakkou, S. Rostom, R. Bahiri, and N. Hajjaj-Hassouni, “Paraneoplastic rheumatic syndromes: report of eight cases and review of literature,” Rheumatology International, pp. 1–5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Morel, V. Deschamps, E. Toussirot et al., “Characteristics and survival of 26 patients with paraneoplastic arthritis,” Annals of the Rheumatic Diseases, vol. 67, no. 2, pp. 244–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Matsuhisa, A. Toriihara, K. Kubota, T. Makino, H. Mizusawa, and H. Shibuya, “Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes,” Clinical Nuclear Medicine, vol. 37, no. 1, pp. 39–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Rossi, P. Korkola, H. Pertovaara et al., “PET imaging in a longitudinal non-Hodgkin's lymphoma study: association with tumor volume,” Acta Radiologica, vol. 52, no. 9, pp. 995–1002, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. E. Naschitz, D. Yeshurum, and I. Rosner, “Rheumatic manifestations of occult cancer,” Cancer, vol. 75, pp. 2954–2958, 1995. View at Google Scholar
  7. D. Ennishi, Y. Maeda, M. Niiya, K. Shinagawa, and M. Tanimoto, “Incidental detection of acute lymphoblastic leukemia on [18F]fluorodeoxyglucose positron emission tomography,” Journal of Clinical Oncology, vol. 27, no. 36, pp. e269–e270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Seam, J. E. Janik, D. L. Longo, and V. T. DeVita Jr., “Role of chemotherapy in Hodgkin's lymphoma,” Cancer Journal, vol. 15, no. 2, pp. 150–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Herrmann, A. K. Buck, T. Schuster et al., “Predictive value of initial 18F-FLT uptake in patients with aggressive non-hodgkin lymphoma receiving R-CHOP treatment,” Journal of Nuclear Medicine, vol. 52, no. 5, pp. 690–696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Goldschmidt, O. Or, M. Klein, B. Savitsky, and O. Paltiel, “The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma,” Annals of Hematology, vol. 90, no. 2, pp. 165–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. E. E. Pakos, A. D. Fotopoulos, and J. P. A. Ioannidis, “18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis,” Journal of Nuclear Medicine, vol. 46, no. 6, pp. 958–963, 2005. View at Google Scholar · View at Scopus